The Emerging Evidence for the Use of JAK Inhibitors in Connective Tissue Diseases (CTDs)

Time: 9:00 am
day: Day Two

Details:

  • Detailing the basic science and rationale
  • Providing anecdotal evidence and case reports
  • Updating and describing ongoing clinical trials

Speakers: